Investigative Urology - Results from #4080

REVIEW UroToday

Prostate disease risk factors among a New Zealand cohort - Abstract May 9, 2013

Downregulation of androgen receptor transcription by promoter G-quadruplex stabilization as a potential alternative treatment for castrate-resistant prostate cancer - Abstract May 9, 2013

Quantification of Mesenchymal Stem Cells (MSCs) at sites of human prostate cancer - Abstract May 9, 2013

Fibroblast growth factor, estrogen, and prolactin receptor features in different grades of prostatic adenocarcinoma in elderly men - Abstract May 9, 2013

Serum receptor activator of nuclear factor κB ligand (RANKL) levels predict biochemical recurrence in patients undergoing radical prostatectomy - Abstract May 9, 2013

LXR, prostate cancer and cholesterol: The Good, the Bad and the Ugly - Abstract May 8, 2013

N-cadherin dependent collective cell invasion of prostate cancer cells is regulated by the N-terminus of α-catenin - Abstract May 8, 2013

Molecular markers in sex hormone pathway genes associated with the efficacy of androgen-deprivation therapy for prostate cancer - Abstract May 8, 2013

Antiproliferative effects of zinc-citrate compound on hormone refractory prostate cancer - Abstract May 7, 2013

Identification of transcription factors associated with castration-resistance: Is the serum responsive factor a potential therapeutic target? - Abstract May 7, 2013

Apigenin inhibits TGF-β-induced VEGF expression in human prostate carcinoma cells via a Smad2/3- and Src-dependent mechanism - Abstract May 7, 2013

Genome-wide association study identifies ioci at ATF7IP and KLK2 associated with percentage of circulating free PSA - Abstract May 7, 2013

Anacardic acid (6-pentadecylsalicylic acid) induces apoptosis of prostate cancer cells through inhibition of androgen receptor and activation of p53 signaling - Abstract May 7, 2013

Detection of circulating tumor cells in different stages of prostate cancer - Abstract May 7, 2013

Concurrent AURKA and MYCN gene amplifications are harbingers of lethal treatment-related neuroendocrine prostate cancer - Abstract May 7, 2013

A novel model of urinary tract differentiation, tissue regeneration, and disease: Reprogramming human prostate and bladder cells into induced pluripotent stem cells - Abstract May 7, 2013

Inhibition of protein kinase CK2 reduces CYP24A1 expression and enhances 1,25-dihydroxyvitamin D3 anti-tumor activity in human prostate cancer cells - Abstract May 6, 2013

Role of CEACAM1 and CEACAM20 in an in vitro model of prostate morphogenesis - Abstract May 6, 2013

Novel Hsp90 inhibitor NVP-AUY922 radiosensitizes prostate cancer cells - Abstract May 6, 2013

Expression of osteoprotegerin from a replicating adenovirus inhibits the progression of prostate cancer bone metastases in a murine model - Abstract May 6, 2013

Page 205 of 346